Bozitinib
目录号: A18554
c-MET kinase 抑制剂
Bozitinib (PLB-1001) 是一种高度选择性的 c-MET 激酶抑制剂,具有血脑屏障渗透性。Bozitinib (PLB-1001) 是一种与酪氨酸激酶超家族的传统 ATP-结合口袋 结合的 ATP-竞争性小分子抑制剂。
Discription | Bozitinib (PLB-1001) is a highly selective c-MET kinase inhibitor with blood-brain barrier permeability. Bozitinib (PLB-1001) is a ATP-competitive small-molecule inhibitor, binds to the conventional ATP-binding pocket of the tyrosine kinase superfamily. |
---|
目录号 | A18554 |
---|---|
分子式 | C20H15F3N8 |
分子量 | 424.38 |
CAS号 | 1440964-89-5 |
SMILES | CN1N=C2C=C(F)C(C(C3=NN=C4C=CC(C5=CN(C6CC6)N=C5)=NN43)(F)F)=CC2=C1 |
其他名称 | PLB-1001, PLB1001, PLB 1001 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 79 mg/mL (186.15 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.56 mL | 117.82 mL | 235.64 mL |
0.5 mM | 4.71 mL | 23.56 mL | 47.13 mL |
1 mM | 2.36 mL | 11.78 mL | 23.56 mL |
5 mM | 0.47 mL | 2.36 mL | 4.71 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2